marijuana stocks news

Form 8-K for LEXARIA CORP.


26-Jun-2015

Termination of a Material Definitive Agreement, Regulation FD Disclosure, Financial

Item 1.02 Termination of a Material Definitive AgreementOn June 24, 2015, the Company entered into Share Purchase Agreement with Shaxon Enterprises Ltd. which replaces the Letter of Intent dated June 10, 2015. Lexaria sold its 49% interest with the MMPR Burlington application number 10-MM0610. The Share Purchase Agreement attached hereto as exhibit 10.1 to this current report. The Burlington project related with Joint Venture Agreement dated May 28, 2014 with Enertopia Corp. based on developing a business of legally producing, manufacturing, propagating, importing/exporting, testing, researching and developing marijuana at the Burlington Location. This Joint Venture was terminated based on the closing of this transaction.

 

Item 7.01 Regulation FD Disclosure.A copy of the news release announcing Letter of Intent and cancellation of Enertopia/Lexaria Joint Venture Agreement is filed as exhibit 99.1 to this current report and is hereby incorporated by reference.

 

ITEM 9.01. FINANCIAL STATEMENTS AND EXHIBITS.(d) Exhibits.

Exhibit No.                    Description

   10.1       Share Purchase Agreement dated June 24, 2015
   99.1       News Release dated June 25, 2015

 


MAPH Enterprises, LLC | (305) 414-0128 | 1501 Venera Ave, Coral Gables, FL 33146 | new@marijuanastocks.com
Leave a Reply

Your email address will not be published. Required fields are marked *

You May Also Like

Tauriga Sciences, Inc. (TAUG) Fully Repays $27,500 Face Value 8.00% Convertible Debenture Issued to Adar Bays, LLC

Tauriga Sciences, Inc. Fully Repays $27,500 Face Value 8.00% Convertible Debenture Issued…

Verano Holdings Corp. (VRNOF) to Open 36th MÜV Florida Medical Cannabis Dispensary in Downtown Tampa

Verano to Open 36th MÜV Florida Medical Cannabis Dispensary in Downtown Tampa…

Tetra Bio-Pharma Inc. (TBPMF) Announces Closing of Bought Deal Financing

Tetra Bio-Pharma Announces Closing of Bought Deal Financing Tetra Bio-Pharma Inc. (“Tetra”…

InMed Pharmaceuticals Inc. (IMLFF) Continues to Strengthen Biosynthesis Patent Family

InMed Pharmaceuticals Continues to Strengthen Biosynthesis Patent Family InMed Pharmaceuticals Inc. (“InMed” or…